Early Diabetes Intervention Trial
Completed
- Conditions
- Impaired glucose toleranceNutritional, Metabolic, EndocrineDiabetes
- Registration Number
- ISRCTN96631607
- Lead Sponsor
- Bayer plc and Merck-Lipha (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 631
Inclusion Criteria
Subjects aged 30 to 70 years inclusive, with fasting hyperglycaemia; defined as a fasting plasma glucose (FPG) level =5.5 mmol/l and <7.8 mmol/l on two occasions at least 1 week apart
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration